Fig. 5From: Development of [225Ac]Ac-DOTA-C595 as radioimmunotherapy of pancreatic cancer: in vitro evaluation, dosimetric assessment and detector calibrationExample flow cytometry graphs demonstrating expression of γH2AX foci on PANC-1 and AsPC-1 cell lines at 1 h, 24 h and 48 h post-exposure to [225Ac]Ac-DOTA-C595 or unlabeled Ac-225. Red peak represents untreated cells; blue peak represents the treated cellsBack to article page